The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue SUPPL. 3, 2006, Pages 118-135

  Romero, R ^a,b   Espinoza, J ^a,b   Gotsch, F ^a,b   Kusanovic, J P ^a,b   Friel, L A ^b   Erez, O ^a,b   Mazaki Tovi, S ^b   Than, N G ^a,b   Hassan, S ^a,b   Tromp, G ^c  

^a HUTZEL WOMEN'S HOSPITAL   (United States)

^b HUTZEL HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analytical tools; Genetics; High throughput; Omics; Predisposing factors; Preterm birth; Preterm labour; Systems biology

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; BETAINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD14 ANTIGEN; CHOLINE; CYANOCOBALAMIN; FAS ANTIGEN; FOLIC ACID; GELATINASE B; HEAT SHOCK PROTEIN 47; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA;

DIET SUPPLEMENTATION; DNA POLYMORPHISM; EPIGENETICS; FEMALE; GENETIC VARIABILITY; GENOMICS; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; METABOLOMICS; NONHUMAN; PATHOGENESIS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; OBSTETRIC LABOR, PREMATURE; PEDIGREE; POLYMORPHISM, GENETIC; PREGNANCY; PRENATAL DIAGNOSIS; PROTEOMICS; TRANSCRIPTION, GENETIC;

EID: 33845567710     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01150.x     Document Type: Review

References (204)

1. Ahn AC, Tewari M, Poon CS, Phillips RS. The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med 2006;3:e208.
2. Strange K. The end of "naive reductionism": rise of systems biology or renaissance of physiology? Am J Physiol Cell Physiol 2005;288:C968-74.
3. Evans GA. Designer science and the "omic" revolution. Nat Biotechnol 2000;18:127.
4. Gracey AY, Cossins AR. Application of microarray technology in environmental and comparative physiology. Annu Rev Physiol 2003;65:231-59.
5. Mehta T, Tanik M, Allison DB. Towards sound epistemological foundations of statistical methods for HDB. Nat Genet 2004;36:943-7.
6. Webster's Third New International Dictionary. G&L Merrinian, Co., Springfield, MA, 1981.
7. Weinstein JN. Fishing expeditions. Science 1998;282:628-9.
8. Weinstein JN. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr Opin Pharmacol 2002;2:361-5.
9. Coulton G. Are histochemistry and cytochemistry 'Omics'? J Mol Histol 2004;35:603-13.
10. Kitano H. Looking beyond the details: a rise in system-oriented approaches in genetics andmolecular biology. Curr Genet 2002;41:1-10.
11. Kitano H. Systems biology: a brief overview. Science 2002;295:1662-4.
12. Hood L. Leroy Hood expounds the principles, practice and future of systems biology. Drug Discov Today 2003;8:436-8.
13. Hood L. Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 2003;124:9-16.
14. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-3.
15. Ahn AC, Tewari M, Poon CS, Phillips RS. The clinical applications of a systems approach. PLoS Med 2006;3:e209.
16. Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001;286:2322-4.
17. Collins FS, Mansoura MK. The Human Genome Project. Revealing the shared inheritance of all humankind. Cancer 2001;91:221-5.
18. Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol 2001;19:491-6.
19. McKusick VA. The anatomy of the human genome: a neo-Vesalian basis for medicine in the 21st century. JAMA 2001;286:2289-95.
20. Subramanian G, Adams MD, Venter JC, Broder S. Implications of the human genome for understanding human biology and medicine. JAMA 2001;286:2296-307.
21. Nolte DL, Mason JR. Maternal ingestion of ortho-aminoacetophenone during gestation affects intake by offspring. Physiol Behav 1995;58:925-8.
22. Hudson R, Cruz Y, Lucio A, Ninomiya J, Martinez-Gomez M. Temporal and behavioral patterning of parturition in rabbits and rats. Physiol Behav 1999;66:599-604.
23. Nathanielsz PW. Comparative studies on the initiation of labor. Eur J Obstet Gynecol Reprod Biol 1998;78:127-32.
24. Walker LA, Cornell L, Dahl KD, Czekala NM, Dargen CM, Joseph B, et al. Urinary concentrations of ovarian steroid hormone metabolites and bioactive follicle-stimulating hormone in killer whales (Orcinus orchus) during ovarian cycles and pregnancy. Biol Reprod 1988;39:1013-20.
25. Allen WR, Mathias S, Ford M. Placentation in the African elephant, Loxodonta africana. IV. Growth and function of the fetal gonads. Reproduction 2005;130:713-20.
26. Allen WR, Wilsher S, Turnbull C, Stewart F, Ousey J, Rossdale PD, et al. Influence of maternal size on placental, fetal and postnatal growth in the horse. I. Development in utero. Reproduction 2002;123:445-53.
27. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm paturition syndrome. BJOG 2006;113(Suppl. 3):17-43.
28. Lind J, Wallenburg HC. Pregnancy and the Ehlers-Danlos syndrome: a retrospective study in a Dutch population. Acta Obstet Gynecol Scand 2002;81:293-300.
29. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep 2003;52:1-113.
30. Adams KM, Eschenbach DA. The genetic contribution towards preterm delivery. Semin Fetal Neonatal Med 2004;9:445-52.
31. Varner MW, Esplin MS. Current understanding of genetic factors in preterm birth. BJOG 2005;112(Suppl 1):28-31.
32. Schieve LA, Handler A. Preterm delivery and perinatal death among black and white infants in a Chicago-area perinatal registry. Obstet Gynecol 1996;88:356-63.
33. Odibo AO, Talucci M, Berghella V. Prediction of preterm premature rupture of membranes by transvaginal ultrasound features and risk factors in a high-risk population. Ultrasound Obstet Gynecol 2002;20:245-51.
34. Romero R, Kuivaniemi H, Tromp G, Olson J. The design, execution, and interpretation of genetic association studies to decipher complex diseases. Am J Obstet Gynecol 2002;187:1299-312.
35. Porter TF, Fraser AM, Hunter CY, Ward RH, Varner MW. The risk of preterm birth across generations. Obstet Gynecol 1997;90:63-7.
36. Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998;27:248-54.
37. Clausson B, Lichtenstein P, Cnattingius S. Genetic influence on birthweight and gestational length determined by studies in offspring of twins. BJOG 2000;107:375-81.
38. Treloar SA, Macones GA, Mitchell LE, Martin NG. Genetic influences on premature parturition in an Australian twin sample. Twin Res 2000;3:80-2.
39. Ward K, Argyle V, Meade M, Nelson L. The heritability of preterm delivery. Obstet Gynecol 2005;106:1235-9.
40. Strachan T, Read AP. Human Molecular Genetics. New York, NY: John Wiley & Sons, Inc., 1999.
41. Pennell CE, Jacobsson B, Williams SM, Buus RM, Muglia LJ, Dolan SM, et al. Genetic epidemiological studies of preterm birth: guidelines for research. Am J Obstet Gynecol 2006 in press.
42. Aidoo M, McElroy PD, Kolczak MS, Terlouw DJ, ter Kuile FO, Nahlen B, et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 2001;21:201-11.
43. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of spontaneous pretermbirth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 2005;16:469-77.
44. Chen D, Hu Y, Chen C, Yang F, Fang Z, Wang L, et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 2004;15:466-70.
45. Menon R, Velez DR, Simhan H, Ryckman K, Jiang L, Thorsen P, et al. Multilocus interactions at maternal tumor necrosis factor-alpha, tumor necrosis factor receptors, interleukin-6 and interleukin-6 receptor genes predict spontaneous preterm labor in European-American women. Am J Obstet Gynecol 2006;194:1616-24.
46. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191:2056-67.
47. Orsi NM, Logghe HL, Gopichandran N, Bottomley L, Lynch K, Levene MI, et al. Carriage of a low-secretory phenotype C allele of the interleukin (IL)-6-174 (G/C) polymorphism is associated with preterm delivery and idiopathic preterm labour (<32 weeks). J Soc Gynecol Investig 2003;2:320A (abstract).
48. Orsi NM, Logghe HL, Gopichandran N, Bottomley L, Lynch K, Levene MI, et al. Carriage of the mutant high-secretory phenotype G allele of the interleukin (IL)-10-1082 (A/G) is associated with preterm delivery and premature rupture of membranes (<32 weeks). J Soc Gynecol Investig 2003;2:318A (abstract).
49. Greenfield PJ, Kessling AM, Lamont RF. Variation in the interlukin-1beta-511 polymorphism genotype is associated with gestational length in women from the Indian sub-continent who delivered preterm. J Soc Gynecol Investig 2003;2:320A (abstract).
50. Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet Med 2006;8:518-24.
51. Landau R, Xie HG, Dishy V, Stein CM, Wood AJ, Emala CW, et al. Beta2-adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 2002;187:1294-8.
52. Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-302.
53. Wang H, Parry S, Macones G, Sammel MD, Ferrand PE, Kuivaniemi H, et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004;13:2659-69.
54. Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
55. Ferrand PE, Fujimoto T, Chennathukuzhi V, Parry S, Macones GA, Sammel M, et al. The CARD15 2936insC mutation and TLR4 896 A>G polymorphismin African Americans and risk of pretermpremature rupture of membranes (PPROM). Mol Hum Reprod 2002;8:1031-4.
56. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, Holder J, Macones GA, Morgan MA, et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:1297-302.
57. Kalish RB, Vardhana S, Gupta M, Perni SC, Chasen ST, Witkin SS. Polymorphisms in the tumor necrosis factor-alpha gene at position -308 and the inducible 70 kd heat shock protein gene at position +1267 in multifetal pregnancies and preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2004;191:1368-74.
58. Kalish RB, Vardhana S, Gupta M, Chasen ST, Perni SC, Witkin SS. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome. Am J Obstet Gynecol 2003;189:911-14.
59. Genc MR, Gerber S, Nesin M, Witkin SS. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am J Obstet Gynecol 2002;187:157-63.
60. Kalish RB, Vardhana S, Normand NJ, Gupta M, Witkin SS. Association of a maternal CD14 -159 gene polymorphism with preterm premature rupture of membranes and spontaneous preterm birth in multi-fetal pregnancies. J Reprod Immunol 2006;70:109-17.
61. Kalish RB, Nguyen DP, Vardhana S, Gupta M, Perni SC, Witkin SS. A single nucleotide A>G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnancies. Am J Obstet Gynecol 2005;192:208-12.
62. Fuks A, Parton LA, Polavarapu S, Netta D, Strassberg S, Godi I, et al. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 2005;193:1132-6.
63. Wang H, Parry S, Macones G, Sammel MD, Kuivaniemi H, Tromp G, et al. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans. Proc Natl Acad Sci U S A 2006;103:13463-7.
64. Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a HuGE review. Genet Med 2005;7:593-604.
65. Fortunato SJ, Menon R, Swan K, Baricos W. Expression of matrix degrading enzymes and tissue inhibitors of metalloproteinases (TIMP) in human fetal membranes. Presented at 15th annual meeting of the Society of Perinatal Obstetricians. Georgia, January 23-28, Atlanta, 1995 (abstract).
66. Fortunato SJ, Menon R, Lombardi S. Induction of MMP-9 and normal presence of MMP-2, TIMP-1and 2 in human fetal membranes. 17th annual meeting of the Society of Perinatal Obstetricians Anaheim. Am J Obstet Gynecol 1997;176:1.
67. Fortunato SJ, LaFleur B, Menon R. Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am J Reprod Immunol 2003;49:120-5.
68. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss JF III. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-6.
69. th percentile area marker for subsequent preterm rupture of membrane. Am J Obstet Gynecol 2005;192:109-13.
70. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183:94-9.
71. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:2327-33.
72. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-65.
73. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005;331:877.
74. Levine P, Katzin EM, Burham L. Isoimmunization in pregnancy: Its possible bearing on etiology of erythroblastosis foetalis. JAMA 1941;116:825.
75. Sinsheimer JS, Palmer CG, Woodward JA. Detecting genotype combinations that increase risk for disease: maternal-fetal genotype incompatibility test. Genet Epidemiol 2003;24:1-13.
76. Urbaniak SJ. Alloimmunity to RhD in humans. Transfus Clin Biol 2006;13:19-22.
77. Driscoll CA, Menotti-Raymond M, Nelson G, Goldstein D, O'Brien SJ. Genomic microsatellites as evolutionary chronometers: a test in wild cats. Genome Res 2002;12:414-23.
78. Burger PA, Steinborn R, Walzer C, Petit T, Mueller M, Schwarzenberger F. Analysis of the mitochondrial genome of cheetahs (Acinonyx jubatus) with neurodegenerative disease. Gene 2004;338:111-19.
79. Friel L, Kuivaniemi H, Gomez R, Goddard K, Nien JK, Tromp G, et al. Genetic predisposition for preterm PROM: results of a large candidate-gene association study of mothers and their offspring. Am J Obstet Gynecol 2005;6:S17 (abstract).
80. Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss JF III. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004;190:1504-8.
81. Harvesting the fruits of the human genome. Nat Genet 2001;27:227-8.
82. The International HapMap Project. Nature 2003;426:789-96.
83. Kukita Y, Miyatake K, Stokowski R, Hinds D, Higasa K, Wake N, et al. Genome-wide definitive haplotypes determined using a collection of complete hydatidiform moles. Genome Res 2005;15:1511-18.
84. Pollack JR, Iyer VR. Characterizing the physical genome. Nat Genet 2002;32(Suppl):515-21.
85. Hennah W, Varilo T, Paunio T, Peltonen L. Haplotype analysis and identification of genes for a complex trait: examples from schizophrenia. Ann Med 2004;36:322-31.
86. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004;429:446-52.
87. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-36.
88. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-32.
89. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
90. Phizicky E, Bastiaens PI, Zhu H, Snyder M, Fields S. Protein analysis on a proteomic scale. Nature 2003;422:208-15.
91. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
92. Vuadens F, Benay C, Crettaz D, Gallot D, Sapin V, Schneider P, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 2003;3:1521-5.
93. Buhimschi I, Christner R, Buhimschi C, Chaiworapongsa T, Romero R. Proteomic analysis of preterm parturition: a novel method of identifying the patient at risk for preterm delivery. Am J Obstet Gynecol 2002;6:S55 (abstract).
94. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004;292:462-9.
95. Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, et al. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res 2005;4:2236-42.
96. Klein LL, Reisdorph N, Jonscher KR, Kushner EJ, Gibbs RS, McManaman JL. A novel method for vaginal proteomics in preterm labor. J Soc Gynecol Investig 2006;2:144A (abstract).
97. Romero R, Chaiworapongsa T, Gomez R, Kim YM, Edwin S, Bujold E, et al. Proteomic profiling of premature labor: a method to identify clinical biomarkers and mechanisms of disease. Am J Obstet Gynecol 2003;6(Suppl 1):S63 (abstract).
98. Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805-16.
99. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993;30:167-83.
100. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-70.
101. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
102. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11.
103. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.
104. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-81.
105. Nien JK, Yoon BH, Espinoza J, Kusanovic JP, Erez O, Soto E, et al. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol 2006;195:1025-30.
106. Maymon E, Romero R, Chaiworapongsa T, Berman S, Conoscenti G, Gomez R, et al. Amniotic fluidmatrixmetalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol 2001;185:1149-55.
107. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of midtrimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001;185:1162-7.
108. Angus SR, Segel SY, Hsu CD, Locksmith GJ, Clark P, Sammel MD, et al. Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol 2001;185:1232-8.
109. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY, et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 2001;185:1156-61.
110. Shim SS, Romero R, Hong JS, Park CW, Jun JK, Kim BI, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339-45.
111. Romero R, Gomez R, Nien JK, Yoon BH, Luo R, Beecher C, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. Am J Obstet Gynecol 2004;6(Suppl 1):S2 (abstract).
112. Gutierres SL, Welty TE. Point-of-care testing: an introduction. Ann Pharmacother 2004;38:119-25.
113. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN Jr, Bennett WA. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001;98:476-80.
114. Sadowsky DW, Novy MJ, Witkin SS, Gravett MG. Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003;188:252-63.
115. Beloosesky R, Gayle DA, Ross MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol 2006;195:1053-7.
116. Hegde PS, White IR, Debouck C. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol 2003;14:647-51.
117. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
118. Lipshutz RJ, Morris D, Chee M, Hubbell E, Kozal MJ, Shah N, et al. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 1995;19:442-7.
119. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, et al. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 2003;5:57-8.
120. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
121. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
122. Helmer H, Dobianer K, Koukal T, Husslein P. Quantitative polymerase chain reaction for determination of different oxytocin receptor mRNA expression in non-pregnant and pregnant uterine tissue. Adv Exp Med Biol 1995;395:487-8.
123. Chien EK, Tokuyama Y, Rouard M, Phillippe M, Bell GI. Identification of gestationally regulated genes in rat myometrium by use of messenger ribonucleic acid differential display. Am J Obstet Gynecol 1997;177:645-52.
124. Sparey C, Robson SC, Bailey J, Lyall F, Europe-Finner GN. The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor. J Clin Endocrinol Metab 1999;84:1705-10.
125. Wu WX, Zhang Q, Ma XH, Unno N, Nathanielsz PW. Suppression subtractive hybridization identified a marked increase in thrombospondin-1 associated with parturition in pregnant sheep myometrium. Endocrinology 1999;140:2364-71.
126. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21:514-50.
127. Wu WX, Zhang Q, Unno N, Derks JB, Nathanielsz PW. Characterization of decorin mRNA in pregnant intrauterine tissues of the ewe and regulation by steroids. Am J Physiol Cell Physiol 2000;278:C199-206.
128. Bethin KE, Nagai Y, Sladek R, Asada M, Sadovsky Y, Hudson TJ, et al. Microarray analysis of uterine gene expression in mouse and human pregnancy. Mol Endocrinol 2003;17:1454-69.
129. Charpigny G, Leroy MJ, Breuiller-Fouche M, Tanfin Z, Mhaouty-Kodja S, Robin P, et al. A functional genomic study to identify differential gene expression in the preterm and term human myometrium. Biol Reprod 2003;68:2289-96.
130. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition - a review. Placenta 2003;24(Suppl A):S33-46.
131. Esplin MS, Fausett MB, Peltier MR, Hamblin S, Silver RM, Branch DW, et al. The use of cDNA microarray to identify differentially expressed labor-associated genes within the human myometrium during labor. Am J Obstet Gynecol 2005;193:404-13.
132. Michaelis SA, Okuducu AF, Sarioglu NM, von Deimling A, Dudenhausen JW. The transcription factor Ets-1 is expressed in human amniochorionic membranes and is up-regulated in term and preterm premature rupture of membranes. J Perinat Med 2005;33:314-19.
133. Lindstrom T, Loudon J, Bennett P. Transcriptional regulation of labour-associated genes. In: Norman J, Greer I, editors. Preterm Labour. Managing Risk in a Clinical Practice. Cambridge, UK: Cambridge University Press; 2005. pp. 76-108.
134. Havelock JC, Keller P, Muleba N, Mayhew BA, Casey BM, Rainey WE, et al. Human myometrial gene expression before and during parturition. Biol Reprod 2005;72:707-19.
135. Huber A, Hudelist G, Czerwenka K, Husslein P, Kubista E, Singer CF. Gene expression profiling of cervical tissue during physiological cervical effacement. Obstet Gynecol 2005;105:91-8.
136. Word RA, Landrum CP, Timmons BC, Young SG, Mahendroo MS. Transgene insertion on mouse chromosome 6 impairs function of the uterine cervix and causes failure of parturition. Biol Reprod 2005;73:1046-56.
137. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab 2002;87:2431-4.
138. Weston GC, Ponnampalam A, Vollenhoven BJ, Healy DL, Rogers PA. Genomics in obstetrics and gynaecology. Aust N Z J Obstet Gynaecol 2003;43:264-72.
139. Wilson RD. Genomics: new technology for obstetrics. J Obstet Gynaecol Can 2005;27:63-75.
140. Tarca AL, Romero R, Draghici S. Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol 2006;195:373-88.
141. Romero R, Tromp G. High-dimensional biology in obstetrics and gynecology: functional genomics in microarray studies. Am J Obstet Gynecol 2006;195:360-3.
142. Ward K. Microarray technology in obstetrics and gynecology: a guide for clinicians. Am J Obstet Gynecol 2006;195:364-72.
143. Mason CW, Swaan PW, Weiner CP. Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 2006;194:1513-23.
144. Aguan K, Carvajal JA, Thompson LP, Weiner CP. Application of a functional genomics approach to identify differentially expressed genes in human myometrium during pregnancy and labour. Mol Hum Reprod 2000;6:1141-5.
145. Chan EC, Fraser S, Yin S, Yeo G, Kwek K, Fairclough RJ, et al. Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study. J Clin Endocrinol Metab 2002;87:2435-41.
146. Tromp G, Kuivaniemi H, Romero R, Chaiworapongsa T, Kim YM, Kim MR, et al. Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes. Am J Obstet Gynecol 2004;191:1331-8.
147. Helmig BR, Romero R, Espinoza J, Chaiworapongsa T, Bujold E, Gomez R, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med 2002;12:237-46.
148. Tashima LS, Millar LK, Bryant-Greenwood GD. Genes upregulated in human fetal membranes by infection or labor. Obstet Gynecol 1999;94:441-9.
149. Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, Mazor M, et al. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006;195:394. e1-24.
150. Bisits AM, Smith R, Mesiano S, Yeo G, Kwek K, MacIntyre D, et al. Inflammatory aetiology of human myometrial activation tested using directed graphs. PLoS Comput Biol 2005;1:132-6.
151. Hassan SS, Romero R, Haddad R, Hendler I, Khalek N, Tromp G, et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006;195:778-86.
152. Bukowski R, Hankins GD, Saade GR, Anderson GD, Thornton S. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med 2006;3:e169.
153. Romero R, Tarca AL, Tromp G. Insights into the physiology of childbirth using transcriptomics. PLoS Med 2006;3:e276.
154. Muhle RA, Pavlidis P, Grundy WN, Hirsch E. A high-throughput study of gene expression in preterm labor with a subtractive microarray approach. Am J Obstet Gynecol 2001;185:716-24.
155. Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from themurine model. J Soc Gynecol Investig 2005;12:145-55.
156. Haddad R, Gould BR, Romero R, Tromp G, Farookhi R, Edwin SS, et al. Uterine transcriptomes of bacteria-induced and ovariectomy-induced preterm labor in mice are characterized by differential expression of arachidonate metabolism genes. Am J Obstet Gynecol 2006;195:822-8.
157. Pennell CE, Oldenhof AD, Perkins JE, Dunk CE, Keunen J, Tan P, et al. Identification of a gene expression signature in leukocytes that predicts preterm delivery in women with threatened preterm labour. J Soc Gynecol Investig 2006;2(Suppl):175A (abstract).
158. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004;22:245-52.
159. Nobeli I, Thornton JM. A bioinformatician's view of the metabolome. Bioessays 2006;28:534-45.
160. Jain S, Jayasimhulu K, Clark JF. Metabolomic analysis of molecular species of phospholipids from normotensive and preeclamptic human placenta electrospray ionization mass spectrometry. Front Biosci 2004;9:3167-75.
161. Rochfort S. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod 2005;68:1813-20.
162. Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol 2003;21:692-6.
163. Nielsen J, Oliver S. The next wave in metabolome analysis. Trends Biotechnol 2005;23:544-6.
164. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 2001;19:45-50.
165. Weckwerth W, Loureiro ME, Wenzel K, Fiehn O. Differential metabolic networks unravel the effects of silent plant phenotypes. Proc Natl Acad Sci U S A 2004;101:7809-14.
166. Harrigan GG, Goodacre R. Introduction. In: Harrigan GG, Goodacre R, editors. Metabolic Profiling. Its Role in Biomarker Discovery and Gene Function Analysis. Norwell, MA: Kluwer Academic Publishers; 2003. pp. 1-8.
167. Goodacre R, Timmins EM, Burton R, Kaderbhai N, Woodward AM, Kell DB, et al. Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism fingerprinting and artificial neural networks. Microbiology 1998;144:1157-70.
168. Clarke S, Goodacre R. Raman spectroscopy for whole organism and tissue profiling. In: Harrigan GG, Goodacre R, editors. Metabolic Pro-filing. Its Role in Biomarker Discovery and Gene Function Analysis. Norwell, MA: Kluwer Academic Publishers; 2003. pp. 95-110.
169. Zahn JA, Higgs RE, Hilton MD. Use of direct-infusion electrospray mass spectrometry to guide empirical development of improved conditions for expression of secondary metabolites from actinomycetes. Appl Environ Microbiol 2001;67:377-86.
170. Kenny LC, Dunn WB, Ellis DI, Myers JE, Robinson AE, Kell DB, et al. Novel biomarkers for preeclampsia detected using metabolomics and machine learning. J Soc Gynecol Investig 2005;2(Suppl):199A (abstract).
171. Kenny LC, Harding KEL, Ellis DI, Broadhurst D, Dunn WB, Kell DB, et al. Rapid high-throughput detection of preeclampsia. J Soc Gynecol Investig 2006;2(Suppl):124A (abstract).
172. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 1999;286:481-6.
173. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33(Suppl):245-54.
174. Callinan PA, Feinberg AP. The emerging science of epigenomics. Hum Mol Genet 2006;15:R95-101.
175. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002;3:662-73.
176. Vanden BW, Ndlovu MN, Hoya-Arias R, Dijsselbloem N, Gerlo S, Haegeman G. Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochem Pharmacol 2006;30;72:1114-31.
177. Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet 1995;4:1751-5.
178. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-13.
179. Crews D, McLachlan JA. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 2006;147:S4-10.
180. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63-8.
181. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr 2002;22:255-82.
182. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949-57.
183. Scholl TO, Hediger ML, Schall JI, Khoo CS, Fischer RL. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 1996;63:520-5.
184. Valdez LL, Quintero A, Garcia E, Olivares N, Celis A, Rivas F Jr, et al. Thrombophilic polymorphisms in preterm delivery. Blood Cells Mol Dis 2004;33:51-6.
185. Johnson WG, Scholl TO, Spychala JR, Buyske S, Stenroos ES, Chen X. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery. Am J Clin Nutr 2005;81:664-8.
186. Scholl TO, Hediger ML, Schall JI, Fischer RL, Khoo CS. Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am J Epidemiol 1993;137:1115-24.
187. Goldenberg RL, Tamura T, Neggers Y, Copper RL, Johnston KE, DuBard MB, et al. The effect of zinc supplementation on pregnancy outcome. JAMA 1995;274:463-8.
188. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999;181:359-66.
189. Wickelgren I. Premature labor. Resetting pregnancy's clock. Science 2004;304:666-8.
190. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. J Clin Endocrinol Metab 2004;89:2365-72.
191. Lindstrom TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005;130:569-81.
192. Mendelson CR, Condon JC. New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol Biol 2005;93:113-19.
193. Ackerman WE, Zhang XL, Rovin BH, Kniss DA. Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. Biol Reprod 2005;73:527-35.
194. Lindstrom TM, Bennett PR. 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. J Clin Endocrinol Metab 2005;90:3534-43.
195. Condon JC, Hardy DB, Mendelson CR. Upregulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of NF-kB may contribute to the onset of labor through inhibition of PR function. J Soc Gynecol Investig 2006;2:65A (abstract).
196. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93.
197. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
198. Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 2005;65:4673-82.
199. Peng B, Hodge DR, Thomas SB, Cherry JM, Munroe DJ, Pompeia C, et al. Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 2005;280:4182-7.
200. Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA, et al. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res 2004;64:3465-73.
201. Croonquist PA, Van NB. The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene 2005;24:6269-80.
202. Armenante F, Merola M, Furia A, Palmieri M. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 1999;258:644-7.
203. Condon JC, Jeyasuria P, Faust JM, Wilson JW, Mendelson CR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A 2003;100:9518-23.
204. Mitchell MD. Unique suppression of prostaglandin H synthase-2 expression by inhibition of histone deacetylation, specifically in human amnion but not adjacent choriodecidua. Mol Biol Cell 2006;17:549-53.